Investigating Specific Gait Patterns in Individuals Living With Multiple Sclerosis
GAIT-MS
2 other identifiers
observational
30
1 country
1
Brief Summary
The study aims to investigate specific ambulation patterns characteristic of the quality of gait in people with MS (pwMS)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Mar 2026
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 28, 2026
CompletedFirst Posted
Study publicly available on registry
February 5, 2026
CompletedStudy Start
First participant enrolled
March 16, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 1, 2026
March 23, 2026
March 1, 2026
3 months
January 28, 2026
March 20, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
description of ambulation pattern in controlled environment in people living with multiple sclerosis (pwMS) with different disease severities
Measurement of daily life-like activity movements by Optical Motion Capture, pressure sensitive walkway and wearable sensors
enrollment
Study Arms (2)
people living with Multiple Sclerosis
Healthy Adult
Eligibility Criteria
Patients with MS will be recruited from the CHU Lille. Patients will be informed of this study by the Investigator during routine follow-up visits. The Investigator will also connect with local patient organizations and share a flyer. This flyer will also be displayed within the Neurology and Neurological Rehabilitation departments of the hospital and diffused to the hospital staff.
You may qualify if:
- For people living with multiple sclerosis (pwMS):
- Signed informed consent and ability to comply with study and follow-up.
- Confirmed MS diagnosis according to McDonald criteria (2017)
- Expanded Disability Status Scale EDSS = 6
- Ability and willingness to participate in and comply with all study procedures defined in the protocol
- Subject will be eligible for enrollment in this study only if either affiliated to, or a beneficiary of a social security category
- For Healthy volunteers :
- Signed informed consent and ability to comply with study and follow-up.
- Ability and willingness to participate in and comply with all study procedures defined in the protocol
- Subject will be eligible for enrollment in this study only if either affiliated to, or a beneficiary of a social security category
You may not qualify if:
- For pwMS:
- Participants with significant cognitive disorders, limiting the understanding of the exercises to be performed or presence of apparent communication difficulties hindering the correct collection of data, as assessed by the investigator
- Past or present pathology other than MS or surgery or trauma impacting gait, ambulatory function or upper limb function, as assessed by the investigator
- Vulnerable adults: individuals subject to a legal protection measure (guardianship, limited guardianship, or judicial protection) or unable to express their consent.
- For healthy volunteers (HV):
- Participants with significant cognitive disorders, limiting the understanding of the exercises to be performed or presence of apparent communication difficulties hindering the correct collection of data, as assessed by the investigator
- Past or present pathology or surgery or trauma impacting gait, ambulatory function or upper limb function, as assessed by the investigator
- Vulnerable adults: individuals subject to a legal protection measure (guardianship, limited guardianship, or judicial protection) or unable to express their consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- SYSNAVlead
Study Sites (1)
CHU Lille
Lille, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Patrick Vermersch
CHU Lille
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 28, 2026
First Posted
February 5, 2026
Study Start
March 16, 2026
Primary Completion (Estimated)
June 1, 2026
Study Completion (Estimated)
June 1, 2026
Last Updated
March 23, 2026
Record last verified: 2026-03